Biomaterials Access Assurance Act of 1998

The Biomaterials Access Assurance Act of 1998 was enacted on August 13, 1998. This act aims to safeguard the continued supply of raw materials and component parts necessary for the production of lifesaving or life-enhancing medical devices in the United States. The law clarifies the permissible bases of liability for suppliers of these raw materials and component parts and provides expeditious procedures to dispose of unwarranted suits against them, minimizing litigation costs.